- G11.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM G11.3 became effective on October 1, 2022.
- This is the American ICD-10-CM version of G11.3 – other international versions of ICD-10 G11.3 may differ.
ICD-10-CM G11.3 is grouped within Diagnostic Related Group(s):
- 058 Multiple sclerosis and cerebellar ataxia with mcc
- 059 Multiple sclerosis and cerebellar ataxia with cc
- 060 Multiple sclerosis and cerebellar ataxia without cc/mcc
Applicable To
- Ataxia telangiectasia [Louis-Bar]
Type 2 Excludes
- Cockayne’s syndrome (Q87.19)
- other disorders of purine and pyrimidine metabolism (E79.-)
- xeroderma pigmentosum (Q82.1)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to G11.3:
- with defective DNA repair > cerebellar (hereditary) G11.9
- telangiectasia (Louis-Bar) > Ataxia, ataxy, ataxic R27.0
- ataxia-telangiectasia > Syndrome
- Boder-Sedgewick > Syndrome
- Louis-Barré > Syndrome
- ataxic (cerebellar) (Louis-Bar) > Telangiectasia, telangiectasis (verrucous) I78.1